Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to evaluate different combinations of cancer education sessions, counseling sessions, and peer support meetings developed for Chinese cancer patients and survivors. The researchers will look at whether the combinations are practical and effective, and how they impact participants' quality of life.
Eligibility criteria
Qualifiers
Diagnosed with cancer (any type/stage) (per EMR for MSK patients or self-report for external participants) within the last 5 years
Age ≥ 18 years (per EMR for MSK patients or self-report for external participants)
Of Chinese descent
Speaks Mandarin "well" or "very well"
Disqualifiers
Per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of > 0 on item 9 of the PHQ-9,5 they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale. They will be excluded from participation in this study if there is presence of suicidal risk, determined by affirmative response(s) on the Columbia-Suicide Severity Rating Scale (C-SSRS)
Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?"
Cognitive impairment (Montreal Cognitive Assessment 5 Minute - telephone version with a score < 12)
Per consenting professional determination, unable to understand the informed consent procedure
Trial design
Treatments tested in this trial
- Cancer Education
- Meaning-Centered Counseling
- Peer Support
- Enhanced Standard Care
Treatment groups
64 Participants
are divided into 8 treatment groups8
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
American Cancer Society, Inc.
Collaborator
Brooklyn College Cancer Center
Collaborator
Herald Cancer Association
Collaborator
Source ClinicalTrials.gov